search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
HEALTH From bench to bedside


Edinburgh academics support digital health innovation from germ of idea to effective treatment


BY DR ANDREA TAYLOR AND DR SARAH BROWN


The Covid-19 pandemic has forced the world to challenge traditional ways of working, in- novate and accelerate transforma- tion, particularly through digital solutions. Nowhere is this more obvious than when it comes to health and the use of data, which has been instrumental in catalys- ing treatment strategies (for example rapid vaccine approval), tracking infection (track and trace apps) and public health (inform- ing outbreak control measures). Te power of data, particu-


larly real-world data comes from linking and aggregating different datasets such as patient health records, genomics, social and environmental data. Tis can be used to generate new actionable insights into disease, accelerate therapeutic development and improve standards of care, result- ing in significant time and cost savings. Te University of Edinburgh


has long recognised the power of real-world data. Using routinely collected hospital data, Profes- sor Nick Mills and co-workers determined that women were under-diagnosed with heart at- tack, findings that have updated the universal definition of heart attack. More recently, the uni- versity, with partners, has been leading the development of new data infrastructures such as the HDR UK BREATHE Hub, which brings together respiratory health data to address conditions such


tory pathways that govern it; maximising potential is reliant on robust data, highly skilled data scientists and collaboration with clinical expertise. Te University of Edinburgh brings these three pillars together, creating a holistic approach to healthcare innova- tion and is actively engaging new partners both academic and industrial. Having held a hugely successful online event “Innova- tions in Digitally Enabled Clinical Trials” last year to catalyse new partnerships, the university is driving forward collaborative and innovative approaches in this space.


The DataLoch project has been using analytics to support hospitals during Covid-19. Photo: FatCamera via Getty Images


as asthma and COPD, and also DataLoch to enable innovation in health interventions.


DataLoch is developing a unique data resource, integrating not just healthcare information but also social care data for the Edinburgh and South East Scotland region to provide a holistic overview of the patient journey. In response to Covid-19, the DataLoch team cu- rated data that supported hospi- tals in managing service provision through the crisis, as well being a living asset that is contributing to regional and national research. As DataLoch grows, there are significant opportunities to use this data to influence and inform therapeutic strategies, contribute to clinical trials through synthetic control arms and improve clinical practice. Te pandemic has also high-


lighted the use of smart tech- nologies and sensors for remote patient monitoring which allows for continuous gathering of data,


22 | FUTURESCOT | SPRING 2021


rather than a reliance on in-clinic assessment. Tis environment can catalyse the development of digi- tal biomarkers. Tese are derived from patient-generated outputs (such as heart rate, movement, temperature etc), collected by wearable sensors, and connected to a health-related outcome. Like molecular biomarkers, these can be used to inform diagnoses, treatments and medical support. Digital biomarkers are par-


ticularly useful in diseases where progression is gradual and early detection is challenging, such as neurodegenerative disorders. For example, Dr Saturnino Luz, (based at the university’s Usher Institute) and his team have been applying machine learning to de- termine vocal biomarkers for the detection of Alzheimer’s disease before clinical symptoms present themselves. As digital health comes of age,


there are still many challenges to overcome, including validation, standardisation and the regula-


It is precisely this kind of joined- up approach that our campaign, Bench to Bedside, aims to showcase. Launched earlier this month by Edinburgh Innovations and the College of Medicine and Veterinary Medicine, it highlights our ability to support digital health innovation from idea, through research and, towards impact via collaboration, licens- ing or the formation of a spin out company. Indeed, our recent track record


underlines that ability – with five spinouts over the last year and significant increases in industry collaborations and translational funding. Our campaign show- cases our world-leading facilities across four different campuses and our academic superstars who have been at the forefront of this innovative activity. What the Bench to Bedside


campaign truly highlights is the impressive breadth of activity and expertise at the University of Edinburgh. With the current transforma-


tion in the digital health sphere our business partners know that, at the University of Edinburgh, they are supported throughout the innovation pipeline, from Bench to Bedside. l


edinburgh-innovations.ed.ac.uk


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44